Market Outlook
The global Artificial Blood Vessel market size was valued at USD 3685.2 million in 2022 and is forecast to a readjusted size of USD 4581.2 million by 2029 with a CAGR of 3.2% during review period.
Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.
The current artificial blood vessels are mostly polyester fibers or PTFE fibers woven into the corrugation of the tube has certain porosity. It implanted in the body which can form a layer of fake endometrial. Due to avoiding coagulation and thrombosis, it’s a better solution to the problem of preventing thrombosis. An organism that can be absorbed by the material emerging non-absorbable material and cross-woven, or on the large pore fabric coating absorbable material (e.g., collagen fibers) of the artificial blood vessel, it is easy to fake endometrial growth acceleration effect better.
Asia-Pacific is the largest artificial blood vessel market with about 38% market share. North America is follower, accounting for about 30% market share. The key players are Getinge, BD(Bard), Terumo etc. Top 1 company occupied about 45% market share.
This report is a detailed and comprehensive analysis for global Artificial Blood Vessel market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Artificial Blood Vessel market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Artificial Blood Vessel market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Artificial Blood Vessel market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Artificial Blood Vessel market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Blood Vessel
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Blood Vessel market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Getinge
BD (Bard)
Terumo
W. L. Gore
Japan Lifeline
B.Braun
LeMaitre Vascular
Suokang
Chest Medical
Segmentation By Type
EPTFE
Polyethylene Terephthalate
Polyurethane
Others
Segmentation By Application
Aortic Disease
Peripheral Artery Disease
Hemodialysis
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the artificial blood vessel market in 2025?
The artificial blood vessel market benefits from technological advancements in biomaterials and tissue engineering, enabling the creation of more durable and effective vessels. Strong regulatory support and increasing investments from the healthcare sector also contribute to its growth. Additionally, the rising demand for organ transplants and the aging population are driving the market’s expansion.
What are the weaknesses of the artificial blood vessel market in 2025?
High production costs and complex manufacturing processes remain significant challenges. Limited scalability of production methods and the difficulty of ensuring long-term functionality in artificial vessels can hinder market growth. Moreover, regulatory hurdles and the need for extensive clinical trials may delay product approvals.
What are the opportunities for the artificial blood vessel market in 2025?
As the global incidence of cardiovascular diseases rises, there is an increased need for artificial blood vessels. Advances in 3D printing and stem cell research offer the potential for more personalized and accessible solutions. Collaboration between biotech companies and research institutions presents opportunities for groundbreaking innovations, and expansion into emerging markets can fuel market growth.
What are the threats to the artificial blood vessel market in 2025?
Competition from alternative treatments like synthetic grafts and bioengineered tissues could threaten market share. Economic factors, such as healthcare budget constraints in certain regions, may limit investment in new technologies. Additionally, safety concerns and public skepticism regarding the long-term performance of artificial blood vessels could slow adoption rates.
Market PESTEL Analysis
What are the political factors affecting the artificial blood vessel market in 2025?
Government regulations and policies around medical devices and healthcare funding are crucial to the development and commercialization of artificial blood vessels. Supportive healthcare policies, especially in developed countries, encourage innovation and approval processes, while political instability in certain regions can create challenges in market access and product distribution.
How do economic factors impact the artificial blood vessel market in 2025?
Economic conditions directly influence healthcare spending. In regions facing economic downturns, there may be budget constraints on healthcare systems, limiting investments in advanced medical technologies. On the other hand, in high-income nations, growing healthcare expenditures provide significant opportunities for market growth, especially with an aging population and increasing demand for complex medical procedures.
What are the social factors influencing the artificial blood vessel market in 2025?
The increasing prevalence of cardiovascular diseases and an aging population are driving the demand for advanced medical solutions like artificial blood vessels. Societal awareness of organ donation issues and the growing acceptance of innovative healthcare technologies also play a critical role in the market’s expansion. Additionally, growing interest in personalized medicine could further accelerate demand.
What technological factors are shaping the artificial blood vessel market in 2025?
Advancements in tissue engineering, biomaterials, and 3D printing technologies are revolutionizing the artificial blood vessel market. These technologies enable the development of more functional, durable, and cost-effective blood vessels. The ongoing integration of artificial intelligence in the design and testing processes also enhances the precision and effectiveness of artificial blood vessels.
What are the environmental factors influencing the artificial blood vessel market in 2025?
Environmental sustainability concerns are leading to increased focus on developing biodegradable or eco-friendly materials for artificial blood vessels. However, manufacturing processes can contribute to environmental challenges, such as waste and energy consumption, which could face scrutiny as environmental regulations tighten.
What legal factors impact the artificial blood vessel market in 2025?
Strict medical device regulations, patent laws, and intellectual property protection are key legal factors shaping the artificial blood vessel market. Companies must navigate complex regulatory frameworks to ensure their products meet safety and efficacy standards, especially as global markets adopt different legal requirements. Additionally, legal challenges around liability and the long-term effects of artificial vessels could pose risks to market growth.
Market SIPOC Analysis
Who are the suppliers in the artificial blood vessel market in 2025?
Suppliers in this market include raw material providers of advanced biomaterials, such as synthetic polymers, collagen, and stem cells. Additionally, manufacturers of medical devices, advanced biotechnologies, and machinery for production are key suppliers, along with research institutions that offer valuable innovations and expertise.
What inputs are needed for the artificial blood vessel market in 2025?
Inputs for the artificial blood vessel market include high-quality raw materials for constructing the vessels, such as synthetic polymers, biological cells, and growth factors. Specialized equipment for manufacturing and testing, along with research data and clinical trials, are also critical components of the input process.
What are the processes involved in the artificial blood vessel market in 2025?
The processes include research and development to design more effective blood vessels, testing and clinical trials to ensure safety and functionality, and manufacturing processes that involve precision engineering and quality control. Regulatory approval and distribution processes also play a key role in bringing the products to market.
Who are the customers in the artificial blood vessel market in 2025?
Customers in the artificial blood vessel market are primarily healthcare providers, including hospitals and clinics specializing in cardiovascular surgery and transplant procedures. Additionally, patients requiring vascular repair or organ transplants, as well as insurance companies and governmental health agencies, are indirect customers.
What outputs are delivered in the artificial blood vessel market in 2025?
The outputs are functional artificial blood vessels that can be implanted into patients for vascular replacement or repair. These outputs include both synthetic and bioengineered vessels, with varying degrees of complexity, durability, and adaptability to human tissues. Additionally, research findings and innovative technologies are secondary outputs contributing to market growth.
Market Porter's Five Forces
How strong is the threat of new entrants in the artificial blood vessel market in 2025?
The threat of new entrants is moderate. While the market holds significant potential, high barriers to entry exist, such as the need for advanced technological expertise, substantial capital investment for research and development, and meeting stringent regulatory requirements. However, emerging biotechnologies and partnerships with research institutions can help new players enter the market.
How intense is the threat of substitutes in the artificial blood vessel market in 2025?
The threat of substitutes is moderate to high. Alternatives like synthetic grafts, bioengineered tissues, and traditional vessel grafting methods (e.g., using veins from the patient) are readily available. However, as artificial blood vessel technology advances, the effectiveness and long-term benefits may reduce the impact of these substitutes.
How powerful is the bargaining power of suppliers in the artificial blood vessel market in 2025?
The bargaining power of suppliers is moderate. The market relies on specialized materials and technologies, which means suppliers of high-quality biomaterials and production equipment hold a certain level of power. However, as the market grows and alternative materials and suppliers become available, this power may diminish over time.
How strong is the bargaining power of buyers in the artificial blood vessel market in 2025?
The bargaining power of buyers is moderate. Hospitals and healthcare providers are the main buyers, and their power is influenced by their purchasing volumes and the availability of competing products. However, as artificial blood vessel technologies become more specialized and personalized, their unique benefits may reduce buyers' ability to negotiate prices significantly.
How competitive is the rivalry among existing firms in the artificial blood vessel market in 2025?
The rivalry among existing firms is high. As the market grows, established companies are competing to innovate and capture market share. There are also numerous small and emerging players entering the space with new technologies and solutions. Companies must continuously invest in R&D and clinical trials to stay ahead of the competition and meet the evolving demands of the healthcare sector.
Market Upstream Analysis
What are the key inputs needed for the artificial blood vessel market in 2025?
The key inputs include advanced biomaterials such as synthetic polymers, collagen, and elastin, as well as stem cells and growth factors for bioengineering. Specialized manufacturing equipment, high-quality medical-grade components, and research data for developing improved blood vessel models are also crucial inputs.
Who are the main suppliers in the artificial blood vessel market in 2025?
Suppliers include companies that provide raw materials for creating the artificial vessels, such as synthetic polymers and biological components. Additionally, suppliers of advanced biotechnological tools, 3D printing technologies, and clinical research institutions that contribute to product development and testing play an essential role in the upstream supply chain.
What are the challenges in the upstream supply chain for the artificial blood vessel market in 2025?
Challenges include the complexity and high cost of sourcing high-quality materials that mimic the properties of human blood vessels. The limited availability of specialized materials, coupled with strict regulatory standards for medical-grade components, can further complicate the supply chain. Additionally, ensuring consistent supply while maintaining high production standards is a significant challenge.
How do regulatory requirements impact the upstream supply chain in the artificial blood vessel market in 2025?
Regulatory requirements significantly impact the upstream supply chain as all materials and manufacturing processes must meet stringent health and safety standards. Companies must ensure that raw materials are compliant with medical regulations, and this often requires detailed documentation and testing, which can delay production and increase costs.
What role does innovation play in the upstream supply chain of the artificial blood vessel market in 2025?
Innovation plays a vital role by enabling the development of new materials and technologies that improve the performance of artificial blood vessels. Advances in biomaterials, such as biodegradable polymers and 3D bioprinting, help reduce costs and improve the quality of the final product. Research partnerships and continuous innovation are key to overcoming supply chain challenges and meeting evolving market needs.
Market Midstream Analysis
What are the key processes in the midstream phase of the artificial blood vessel market in 2025?
The key processes in the midstream phase include the manufacturing of artificial blood vessels using advanced biotechnologies, such as tissue engineering and 3D printing. This stage also involves quality control and clinical trials to ensure safety, functionality, and compliance with regulatory standards before products are ready for distribution.
What are the main challenges in the midstream phase of the artificial blood vessel market in 2025?
Challenges include maintaining high standards of quality during the manufacturing process, scaling up production to meet demand, and ensuring the durability and compatibility of the artificial vessels with human tissues. Additionally, the complexity of clinical trials and regulatory approvals can slow down the time to market.
Who are the key players involved in the midstream phase of the artificial blood vessel market in 2025?
Key players include specialized medical device manufacturers, biotechnology companies focused on vascular tissue engineering, and research institutions that collaborate on product development and clinical trials. These entities work together to ensure the successful transition of the products from the lab to clinical applications.
What role does technology play in the midstream phase of the artificial blood vessel market in 2025?
Technology plays a crucial role in advancing the manufacturing processes, from improving the precision of 3D printing techniques to developing better materials for artificial blood vessels. Innovations in biotechnology and tissue engineering also enhance the quality and effectiveness of these vessels, contributing to better outcomes in clinical settings.
How does the midstream phase impact the overall market dynamics for artificial blood vessels in 2025?
The midstream phase directly impacts the market by determining the cost, quality, and availability of artificial blood vessels. Efficient manufacturing and successful clinical trials accelerate product availability, which in turn boosts market growth. Any delays or failures during this phase can result in slower market penetration and reduced adoption by healthcare providers.
Market Downstream Analysis
What are the key distribution channels for artificial blood vessels in the market in 2025?
Key distribution channels include hospitals, specialized clinics, and healthcare providers that perform surgeries requiring vascular replacements. Additionally, partnerships with medical device distributors and online platforms for healthcare equipment can facilitate wider access, especially in emerging markets.
What are the main challenges in the downstream phase of the artificial blood vessel market in 2025?
Challenges include limited market penetration in certain regions due to the high cost of artificial blood vessels and the specialized nature of the products. There are also issues with educating healthcare providers on the benefits and usage of these advanced devices, as well as overcoming skepticism regarding long-term functionality.
Who are the primary customers in the downstream phase of the artificial blood vessel market in 2025?
Primary customers include healthcare providers such as hospitals, cardiovascular centers, and transplant units that require artificial blood vessels for surgeries and treatments. Insurance companies, which play a significant role in covering the costs of these procedures, are also key customers in this phase.
What role does customer education play in the downstream phase of the artificial blood vessel market in 2025?
Customer education is vital to ensure healthcare professionals are aware of the benefits, potential risks, and proper usage of artificial blood vessels. It also helps increase patient confidence in these innovative treatments, potentially leading to higher adoption rates in clinical settings.
How does the downstream phase impact market growth for artificial blood vessels in 2025?
The downstream phase directly influences market growth by determining the accessibility and adoption of artificial blood vessels. Widespread distribution, strong relationships with healthcare providers, and effective reimbursement strategies will drive higher demand and, in turn, expand the market. Conversely, limited access and low awareness can hinder growth.
Chapter 1, to describe Artificial Blood Vessel product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Artificial Blood Vessel, with price, sales, revenue and global market share of Artificial Blood Vessel from 2018 to 2023.
Chapter 3, the Artificial Blood Vessel competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Blood Vessel breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Artificial Blood Vessel market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Artificial Blood Vessel.
Chapter 14 and 15, to describe Artificial Blood Vessel sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Artificial Blood Vessel
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Artificial Blood Vessel Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 EPTFE
1.3.3 Polyethylene Terephthalate
1.3.4 Polyurethane
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Artificial Blood Vessel Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Aortic Disease
1.4.3 Peripheral Artery Disease
1.4.4 Hemodialysis
1.5 Global Artificial Blood Vessel Market Size & Forecast
1.5.1 Global Artificial Blood Vessel Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Artificial Blood Vessel Sales Quantity (2018-2029)
1.5.3 Global Artificial Blood Vessel Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Getinge
2.1.1 Getinge Details
2.1.2 Getinge Major Business
2.1.3 Getinge Artificial Blood Vessel Product and Services
2.1.4 Getinge Artificial Blood Vessel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Getinge Recent Developments/Updates
2.2 BD (Bard)
2.2.1 BD (Bard) Details
2.2.2 BD (Bard) Major Business
2.2.3 BD (Bard) Artificial Blood Vessel Product and Services
2.2.4 BD (Bard) Artificial Blood Vessel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BD (Bard) Recent Developments/Updates
2.3 Terumo
2.3.1 Terumo Details
2.3.2 Terumo Major Business
2.3.3 Terumo Artificial Blood Vessel Product and Services
2.3.4 Terumo Artificial Blood Vessel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Terumo Recent Developments/Updates
2.4 W. L. Gore
2.4.1 W. L. Gore Details
2.4.2 W. L. Gore Major Business
2.4.3 W. L. Gore Artificial Blood Vessel Product and Services
2.4.4 W. L. Gore Artificial Blood Vessel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 W. L. Gore Recent Developments/Updates
2.5 Japan Lifeline
2.5.1 Japan Lifeline Details
2.5.2 Japan Lifeline Major Business
2.5.3 Japan Lifeline Artificial Blood Vessel Product and Services
2.5.4 Japan Lifeline Artificial Blood Vessel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Japan Lifeline Recent Developments/Updates
2.6 B.Braun
2.6.1 B.Braun Details
2.6.2 B.Braun Major Business
2.6.3 B.Braun Artificial Blood Vessel Product and Services
2.6.4 B.Braun Artificial Blood Vessel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 B.Braun Recent Developments/Updates
2.7 LeMaitre Vascular
2.7.1 LeMaitre Vascular Details
2.7.2 LeMaitre Vascular Major Business
2.7.3 LeMaitre Vascular Artificial Blood Vessel Product and Services
2.7.4 LeMaitre Vascular Artificial Blood Vessel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 LeMaitre Vascular Recent Developments/Updates
2.8 Suokang
2.8.1 Suokang Details
2.8.2 Suokang Major Business
2.8.3 Suokang Artificial Blood Vessel Product and Services
2.8.4 Suokang Artificial Blood Vessel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Suokang Recent Developments/Updates
2.9 Chest Medical
2.9.1 Chest Medical Details
2.9.2 Chest Medical Major Business
2.9.3 Chest Medical Artificial Blood Vessel Product and Services
2.9.4 Chest Medical Artificial Blood Vessel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Chest Medical Recent Developments/Updates
3 Competitive Environment: Artificial Blood Vessel by Manufacturer
3.1 Global Artificial Blood Vessel Sales Quantity by Manufacturer (2018-2023)
3.2 Global Artificial Blood Vessel Revenue by Manufacturer (2018-2023)
3.3 Global Artificial Blood Vessel Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Artificial Blood Vessel by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Artificial Blood Vessel Manufacturer Market Share in 2022
3.4.2 Top 6 Artificial Blood Vessel Manufacturer Market Share in 2022
3.5 Artificial Blood Vessel Market: Overall Company Footprint Analysis
3.5.1 Artificial Blood Vessel Market: Region Footprint
3.5.2 Artificial Blood Vessel Market: Company Product Type Footprint
3.5.3 Artificial Blood Vessel Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Artificial Blood Vessel Market Size by Region
4.1.1 Global Artificial Blood Vessel Sales Quantity by Region (2018-2029)
4.1.2 Global Artificial Blood Vessel Consumption Value by Region (2018-2029)
4.1.3 Global Artificial Blood Vessel Average Price by Region (2018-2029)
4.2 North America Artificial Blood Vessel Consumption Value (2018-2029)
4.3 Europe Artificial Blood Vessel Consumption Value (2018-2029)
4.4 Asia-Pacific Artificial Blood Vessel Consumption Value (2018-2029)
4.5 South America Artificial Blood Vessel Consumption Value (2018-2029)
4.6 Middle East and Africa Artificial Blood Vessel Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Artificial Blood Vessel Sales Quantity by Type (2018-2029)
5.2 Global Artificial Blood Vessel Consumption Value by Type (2018-2029)
5.3 Global Artificial Blood Vessel Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Artificial Blood Vessel Sales Quantity by Application (2018-2029)
6.2 Global Artificial Blood Vessel Consumption Value by Application (2018-2029)
6.3 Global Artificial Blood Vessel Average Price by Application (2018-2029)
7 North America
7.1 North America Artificial Blood Vessel Sales Quantity by Type (2018-2029)
7.2 North America Artificial Blood Vessel Sales Quantity by Application (2018-2029)
7.3 North America Artificial Blood Vessel Market Size by Country
7.3.1 North America Artificial Blood Vessel Sales Quantity by Country (2018-2029)
7.3.2 North America Artificial Blood Vessel Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Artificial Blood Vessel Sales Quantity by Type (2018-2029)
8.2 Europe Artificial Blood Vessel Sales Quantity by Application (2018-2029)
8.3 Europe Artificial Blood Vessel Market Size by Country
8.3.1 Europe Artificial Blood Vessel Sales Quantity by Country (2018-2029)
8.3.2 Europe Artificial Blood Vessel Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Artificial Blood Vessel Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Artificial Blood Vessel Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Artificial Blood Vessel Market Size by Region
9.3.1 Asia-Pacific Artificial Blood Vessel Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Artificial Blood Vessel Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Artificial Blood Vessel Sales Quantity by Type (2018-2029)
10.2 South America Artificial Blood Vessel Sales Quantity by Application (2018-2029)
10.3 South America Artificial Blood Vessel Market Size by Country
10.3.1 South America Artificial Blood Vessel Sales Quantity by Country (2018-2029)
10.3.2 South America Artificial Blood Vessel Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Artificial Blood Vessel Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Artificial Blood Vessel Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Artificial Blood Vessel Market Size by Country
11.3.1 Middle East & Africa Artificial Blood Vessel Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Artificial Blood Vessel Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Artificial Blood Vessel Market Drivers
12.2 Artificial Blood Vessel Market Restraints
12.3 Artificial Blood Vessel Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Artificial Blood Vessel and Key Manufacturers
13.2 Manufacturing Costs Percentage of Artificial Blood Vessel
13.3 Artificial Blood Vessel Production Process
13.4 Artificial Blood Vessel Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Artificial Blood Vessel Typical Distributors
14.3 Artificial Blood Vessel Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Artificial Blood Vessel Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Artificial Blood Vessel Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Getinge Basic Information, Manufacturing Base and Competitors
Table 4. Getinge Major Business
Table 5. Getinge Artificial Blood Vessel Product and Services
Table 6. Getinge Artificial Blood Vessel Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Getinge Recent Developments/Updates
Table 8. BD (Bard) Basic Information, Manufacturing Base and Competitors
Table 9. BD (Bard) Major Business
Table 10. BD (Bard) Artificial Blood Vessel Product and Services
Table 11. BD (Bard) Artificial Blood Vessel Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. BD (Bard) Recent Developments/Updates
Table 13. Terumo Basic Information, Manufacturing Base and Competitors
Table 14. Terumo Major Business
Table 15. Terumo Artificial Blood Vessel Product and Services
Table 16. Terumo Artificial Blood Vessel Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Terumo Recent Developments/Updates
Table 18. W. L. Gore Basic Information, Manufacturing Base and Competitors
Table 19. W. L. Gore Major Business
Table 20. W. L. Gore Artificial Blood Vessel Product and Services
Table 21. W. L. Gore Artificial Blood Vessel Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. W. L. Gore Recent Developments/Updates
Table 23. Japan Lifeline Basic Information, Manufacturing Base and Competitors
Table 24. Japan Lifeline Major Business
Table 25. Japan Lifeline Artificial Blood Vessel Product and Services
Table 26. Japan Lifeline Artificial Blood Vessel Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Japan Lifeline Recent Developments/Updates
Table 28. B.Braun Basic Information, Manufacturing Base and Competitors
Table 29. B.Braun Major Business
Table 30. B.Braun Artificial Blood Vessel Product and Services
Table 31. B.Braun Artificial Blood Vessel Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. B.Braun Recent Developments/Updates
Table 33. LeMaitre Vascular Basic Information, Manufacturing Base and Competitors
Table 34. LeMaitre Vascular Major Business
Table 35. LeMaitre Vascular Artificial Blood Vessel Product and Services
Table 36. LeMaitre Vascular Artificial Blood Vessel Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. LeMaitre Vascular Recent Developments/Updates
Table 38. Suokang Basic Information, Manufacturing Base and Competitors
Table 39. Suokang Major Business
Table 40. Suokang Artificial Blood Vessel Product and Services
Table 41. Suokang Artificial Blood Vessel Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Suokang Recent Developments/Updates
Table 43. Chest Medical Basic Information, Manufacturing Base and Competitors
Table 44. Chest Medical Major Business
Table 45. Chest Medical Artificial Blood Vessel Product and Services
Table 46. Chest Medical Artificial Blood Vessel Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Chest Medical Recent Developments/Updates
Table 48. Global Artificial Blood Vessel Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Artificial Blood Vessel Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Artificial Blood Vessel Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 51. Market Position of Manufacturers in Artificial Blood Vessel, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Artificial Blood Vessel Production Site of Key Manufacturer
Table 53. Artificial Blood Vessel Market: Company Product Type Footprint
Table 54. Artificial Blood Vessel Market: Company Product Application Footprint
Table 55. Artificial Blood Vessel New Market Entrants and Barriers to Market Entry
Table 56. Artificial Blood Vessel Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Artificial Blood Vessel Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Artificial Blood Vessel Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Artificial Blood Vessel Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Artificial Blood Vessel Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Artificial Blood Vessel Average Price by Region (2018-2023) & (USD/Unit)
Table 62. Global Artificial Blood Vessel Average Price by Region (2024-2029) & (USD/Unit)
Table 63. Global Artificial Blood Vessel Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Artificial Blood Vessel Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Artificial Blood Vessel Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Artificial Blood Vessel Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Artificial Blood Vessel Average Price by Type (2018-2023) & (USD/Unit)
Table 68. Global Artificial Blood Vessel Average Price by Type (2024-2029) & (USD/Unit)
Table 69. Global Artificial Blood Vessel Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Artificial Blood Vessel Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Artificial Blood Vessel Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Artificial Blood Vessel Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Artificial Blood Vessel Average Price by Application (2018-2023) & (USD/Unit)
Table 74. Global Artificial Blood Vessel Average Price by Application (2024-2029) & (USD/Unit)
Table 75. North America Artificial Blood Vessel Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Artificial Blood Vessel Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Artificial Blood Vessel Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Artificial Blood Vessel Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Artificial Blood Vessel Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Artificial Blood Vessel Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Artificial Blood Vessel Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Artificial Blood Vessel Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Artificial Blood Vessel Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Artificial Blood Vessel Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Artificial Blood Vessel Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Artificial Blood Vessel Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Artificial Blood Vessel Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Artificial Blood Vessel Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Artificial Blood Vessel Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Artificial Blood Vessel Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Artificial Blood Vessel Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Artificial Blood Vessel Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Artificial Blood Vessel Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Artificial Blood Vessel Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Artificial Blood Vessel Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Artificial Blood Vessel Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Artificial Blood Vessel Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Artificial Blood Vessel Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Artificial Blood Vessel Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Artificial Blood Vessel Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Artificial Blood Vessel Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Artificial Blood Vessel Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Artificial Blood Vessel Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Artificial Blood Vessel Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Artificial Blood Vessel Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Artificial Blood Vessel Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Artificial Blood Vessel Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Artificial Blood Vessel Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Artificial Blood Vessel Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Artificial Blood Vessel Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Artificial Blood Vessel Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Artificial Blood Vessel Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Artificial Blood Vessel Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Artificial Blood Vessel Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Artificial Blood Vessel Raw Material
Table 116. Key Manufacturers of Artificial Blood Vessel Raw Materials
Table 117. Artificial Blood Vessel Typical Distributors
Table 118. Artificial Blood Vessel Typical Customers
List of Figures
Figure 1. Artificial Blood Vessel Picture
Figure 2. Global Artificial Blood Vessel Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Artificial Blood Vessel Consumption Value Market Share by Type in 2022
Figure 4. EPTFE Examples
Figure 5. Polyethylene Terephthalate Examples
Figure 6. Polyurethane Examples
Figure 7. Others Examples
Figure 8. Global Artificial Blood Vessel Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Artificial Blood Vessel Consumption Value Market Share by Application in 2022
Figure 10. Aortic Disease Examples
Figure 11. Peripheral Artery Disease Examples
Figure 12. Hemodialysis Examples
Figure 13. Global Artificial Blood Vessel Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Artificial Blood Vessel Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Artificial Blood Vessel Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Artificial Blood Vessel Average Price (2018-2029) & (USD/Unit)
Figure 17. Global Artificial Blood Vessel Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Artificial Blood Vessel Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Artificial Blood Vessel by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Artificial Blood Vessel Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Artificial Blood Vessel Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Artificial Blood Vessel Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Artificial Blood Vessel Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Artificial Blood Vessel Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Artificial Blood Vessel Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Artificial Blood Vessel Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Artificial Blood Vessel Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Artificial Blood Vessel Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Artificial Blood Vessel Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Artificial Blood Vessel Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Artificial Blood Vessel Average Price by Type (2018-2029) & (USD/Unit)
Figure 32. Global Artificial Blood Vessel Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Artificial Blood Vessel Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Artificial Blood Vessel Average Price by Application (2018-2029) & (USD/Unit)
Figure 35. North America Artificial Blood Vessel Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Artificial Blood Vessel Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Artificial Blood Vessel Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Artificial Blood Vessel Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Artificial Blood Vessel Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Artificial Blood Vessel Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Artificial Blood Vessel Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Artificial Blood Vessel Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Artificial Blood Vessel Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Artificial Blood Vessel Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Artificial Blood Vessel Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Artificial Blood Vessel Consumption Value Market Share by Region (2018-2029)
Figure 55. China Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Artificial Blood Vessel Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Artificial Blood Vessel Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Artificial Blood Vessel Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Artificial Blood Vessel Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Artificial Blood Vessel Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Artificial Blood Vessel Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Artificial Blood Vessel Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Artificial Blood Vessel Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Artificial Blood Vessel Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Artificial Blood Vessel Market Drivers
Figure 76. Artificial Blood Vessel Market Restraints
Figure 77. Artificial Blood Vessel Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Artificial Blood Vessel in 2022
Figure 80. Manufacturing Process Analysis of Artificial Blood Vessel
Figure 81. Artificial Blood Vessel Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
